Pediatric Neurologist Offers Hope to Patients with Genetic Tumor Disorder

Although there is no cure for tuberous sclerosis complex (TSC), a genetic disorder that causes non-malignant tumors to form in many different organs, a pediatric neurologist at Loyola University Chicago Stritch School of Medicine is one of only a few physicians to start using a new drug treatment similar to chemotherapy. If a child’s brain is affected by the disease, it can be especially debilitating since it can cause seizures, developmental delays, intellectual disability and autism. TSC is found in one is every 25,000 children and is not easily diagnosed. The new treatment gives patients and their families another option if response to anti-seizure medications is poor, or the child is not a candidate for surgery. To read more about this, click here.